Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06457841 · ClinicalTrials.gov registry record · NA

Stress and Resilience

A NA study of Cannabis Use and Alcohol Use, sponsored by University of Washington.

Recruiting
Registry status
NA
Development phase
456
Enrollment target
2
Study locations

NCT06457841 is a NA study of Cannabis Use and Alcohol Use that is actively recruiting participants, run by University of Washington. The registered enrollment target is 456 participants, above the 269-participant average among 44 other Cannabis Use trials with a reported enrollment target (70% higher). The trial reports 2 study locations across 2 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06457841, a NA study of Cannabis Use and Alcohol Use, is actively recruiting participants, sponsored by University of Washington.

RECRUITING
Registry status
NA
Development phase
456 participants
Enrollment target
2
Study locations

Study Summary

Alcohol and cannabis are the most misused psychoactive substances in the United States. The proposed research examines how personally relevant stressful experiences may lead to alcohol and cannabis use. The proposed research is also designed to identify possible targets for prevention and treatment efforts to help reduce drug use.

Conditions Studied

Interventions

  • BEHAVIORAL Direct Interpersonal Exchange
  • BEHAVIORAL Vicarious Interpersonal Exchange
  • BEHAVIORAL Daily Hassles

Study Locations (2)

Texas

  • Southern Methodist University - Dallas

Washington

  • University of Washington - Seattle

Trial Details

FieldValue
Enrollment Target 456 participants
Start Date 2024-05-09
Est. Completion 2027-07
Phase NA

Sponsor

University of Washington

1,048 total trials

What the Registry Record Tells You About NCT06457841

The ClinicalTrials.gov registry entry for NCT06457841 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 456 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 269-participant average among 44 other Cannabis Use trials with a reported enrollment target (70% higher). The listed sponsor is University of Washington, which has 1,048 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Cannabis Use appearing as the primary indexed condition, and to 3 interventions - of which Direct Interpersonal Exchange is the first listed.

NCT06457841 reports 2 study locations spanning 2 distinct geographic areas - top geographies include Texas, Washington.

Frequently Asked Questions

What is clinical trial NCT06457841 about?

NCT06457841 is a clinical study titled "Stress and Resilience". Alcohol and cannabis are the most misused psychoactive substances in the United States. The proposed research examines how personally relevant stressful experiences may lead to alcohol and cannabis use. The proposed research is also designed to identify possible targets for prevention and treatment ...

What is the current status of trial NCT06457841?

This trial is currently recruiting. It is a NA study. The enrollment target is 456 participants. The study started on 2024-05-09. Estimated completion is 2027-07.

What conditions does trial NCT06457841 study?

This clinical trial studies the following conditions: Cannabis Use, Alcohol Use.

What interventions are being tested in trial NCT06457841?

The interventions under investigation include: Direct Interpersonal Exchange (BEHAVIORAL), Vicarious Interpersonal Exchange (BEHAVIORAL), Daily Hassles (BEHAVIORAL).

Who is sponsoring clinical trial NCT06457841?

This trial is sponsored by University of Washington, which has 1,048 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06457841 being conducted?

This trial has 2 study locations across Texas, Washington. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Cannabis Use

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.